doc.ai, an advanced natural language processing technology platform for quantified biology, today announced the successful completion of its initial sale of Simple Agreements for Future Tokens (“SAFTs”).
A total of ten purchasers acquired SAFTs, consisting of institutional and other accredited investors, for an aggregate purchase amount of approximately $2.3 million.
The early pre-sale of doc.ai‘s SAFTs, which are convertible into digital tokens named Neurons (“NRNs”), was limited to existing investors and advisors who have either helped support doc.ai in the past, or have demonstrated the desire to partner and support the Neuron Network. Pantera Capital anchored the offering as the lead investor.
“We are excited to be the lead investor in the early SAFT offering by doc.ai,” said Paul Veradittakit, Partner at Pantera Capital. “The company offers an unparalleled innovative technology solution at the intersection of Blockchain and artificial intelligence.”
Anthony Di Iorio, Co-Founder of Ethereum and Founder & CEO of Jaxx, who participated in the early pre-sale, commented: “I am amazed by the potential that doc.ai technology has for millions of people all over the world and possible network effects of the NRN token. I am looking forward to exploring potential synergies between doc.ai and Jaxx.”
“The initial pre-sale demonstrates for doc.ai the confidence of these investors,” commented doc.ai founder and chief executive officer Walter De Brouwer. “We believe that artificial intelligence is poised to revolutionize healthcare and drastically improve patients' care and experience, and our investors have proven their adherence to our vision.”
The pre-sale to eligible investors of SAFTs to acquire doc.ai‘s Neuron (NRN) tokens, based on the ERC-20 standard, commences on September 7, 2017. The crowdsale process is expected to start on September 28, 2017. The solicitation, offer, and sale of SAFTs in all phases will be conducted in a manner that is compliant with applicable securities laws and regulations, including Rule 506(c) of Regulation D. In the United States, only verified accredited investors will be eligible to purchase SAFTs.
For more information visit tokensale.doc.ai.
- Arca Offers The First SEC-Registered Fund Issuing Digital Securities - 6 July 2020
- Binance Teams Up With Chinese Government to Build a New Digital Infrastructure in China - 6 July 2020
- Blockchain Travel Project Travala.com Join Forces with Expedia to Offer Frictionless Cryptocurrency Booking - 6 July 2020